156 related articles for article (PubMed ID: 16294307)
1. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells.
Shim JH; Kim YS; Bahk YY
Proteomics; 2006 Jan; 6(1):81-93. PubMed ID: 16294307
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
[TBL] [Abstract][Full Text] [Related]
3. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH
Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663
[TBL] [Abstract][Full Text] [Related]
4. Proteome changes induced by expression of tumor suppressor PTEN.
Kim SY; Kim YS; Bahk YY
Mol Cells; 2003 Jun; 15(3):396-405. PubMed ID: 12872999
[TBL] [Abstract][Full Text] [Related]
5. Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.
Kusunose M; Hashimoto N; Kimura M; Ogata R; Aoyama D; Sakamoto K; Miyazaki S; Ando A; Omote N; Imaizumi K; Kawabe T; Hasegawa Y
Cancer Sci; 2015 Dec; 106(12):1693-704. PubMed ID: 26450531
[TBL] [Abstract][Full Text] [Related]
6. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
7. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.
Parsa AT; Waldron JS; Panner A; Crane CA; Parney IF; Barry JJ; Cachola KE; Murray JC; Tihan T; Jensen MC; Mischel PS; Stokoe D; Pieper RO
Nat Med; 2007 Jan; 13(1):84-8. PubMed ID: 17159987
[TBL] [Abstract][Full Text] [Related]
8. A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells.
Park JW; Kim S; Bahk YY
Proteomics; 2006 Apr; 6(8):2433-43. PubMed ID: 16612794
[TBL] [Abstract][Full Text] [Related]
9. PTEN at 18: Still Growing.
Gorbenko O; Stambolic V
Methods Mol Biol; 2016; 1388():13-9. PubMed ID: 27033067
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.
Davidson L; Maccario H; Perera NM; Yang X; Spinelli L; Tibarewal P; Glancy B; Gray A; Weijer CJ; Downes CP; Leslie NR
Oncogene; 2010 Feb; 29(5):687-97. PubMed ID: 19915616
[TBL] [Abstract][Full Text] [Related]
11. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade.
Liu JL; Mao Z; LaFortune TA; Alonso MM; Gallick GE; Fueyo J; Yung WK
Cancer Res; 2007 Nov; 67(22):11054-63. PubMed ID: 18006852
[TBL] [Abstract][Full Text] [Related]
14. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
15. PTEN in brain tumors.
Haas-Kogan D; Stokoe D
Expert Rev Neurother; 2008 Apr; 8(4):599-610. PubMed ID: 18416662
[TBL] [Abstract][Full Text] [Related]
16. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness.
Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E
J Cell Biol; 2001 Dec; 155(7):1129-35. PubMed ID: 11756467
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
19. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D
Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733
[TBL] [Abstract][Full Text] [Related]
20. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.
Rong Y; Post DE; Pieper RO; Durden DL; Van Meir EG; Brat DJ
Cancer Res; 2005 Feb; 65(4):1406-13. PubMed ID: 15735028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
